Terminology Service < Semantic Lookup Platform

All terms in BAO

Label	Id	Description
Ollier disease	DOID_4624	[A syndrome that is characterized by an asymmetric distribution of cartilagenous tumors, which may lead to skeletal deformities and limb-length discrepancy. This condition primarily affects the long bones and cartilage of the joints of the arms and legs, specifically the area where the shaft and head of a long bone meet.]
hydranencephaly	DOID_4626
anencephaly	DOID_0060668	[A congenital nervous system abnormality characterized by failure of the anterior neuropore to close resulting in partial or complete absence of the cranial vault accompanied by absence of overlying tissues, including the brain and cerebral hemispheres, skull and scalp.]
nitric oxide donor	CHEBI_50566
donor	CHEBI_17891
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor	CHEBI_50568
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor	CHEBI_50218
bile duct cancer	DOID_4606	[A biliary tract cancer that is located_in the bile duct.]
biliary tract cancer	DOID_4607	[A gastrointestinal system cancer that results_in malignant growth located_in the gallbladder or located_in the bile duct.]
bile duct disease	DOID_4138
biliary tract disease	DOID_9741
gastrointestinal system cancer	DOID_3119	[An organ system cancer located_in gastrointestinal tract that is manifested in organs of the gastrointestinal system.]
EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor	CHEBI_62530
EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor	CHEBI_76878
anti-anaemic agent	CHEBI_75835
epidermolytic hyperkeratosis	DOID_4603
growth inhibition	BAO_0000094	[Growth reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay. As a measure of viable or proliferating cells, different researchers measure different parameters, namely, protein content (by sulforhodamine B staining followed by absorbance measurement), mitochondrial dehydrogenase activity (by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide, known as MTT staining followed by absorbance measurement), expression of proliferation associated antigens (by immunostaining for Ki-67), and ATP content (by using CellTiter-Glo reagent (Promega) followed by luminescence measurement.]
inhibition	BAO_0000091	[Reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.]
stimulation	BAO_0000093	[Increase of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.]
ligand function mode of action	BAO_0000084	[Data measuring the biological effect of a compound, e.g. % cell death, activation of reporter gene expression, inhibition of enzyme activity, etc.]